"Arming the Killer: an Antibody Engineering Perspective for Solid Tumors"

At the conclusion of this activity, the participant will be able to:

1.  Describe the dual specificity antibody targeting in solid cancers
2.  Summarize innovative approaches to improve cancer immunotherapy
3.  Discuss the rational protein engineering in ovarian and breast cancers

 

plate with fork and knife, books, microscope and test tubes
Sponsor(s)
Medicine: Pathology
Speaker(s)
Jogender Tushir-Singh, PhD, U.S. Department of Defense Ovarian Cancer Academy Early Career Investigator Assistant Professor, Biochemistry and Molecular Genetics University of Virginia School of Medicine
Audience
All ( Open to the public )